创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

深共熔溶剂在药物递送系统中的研究进展

Research Progress of Deep Eutectic Solvents in Drug Delivery Systems

  • 摘要: 深共熔溶剂(deep eutectic solvents,DESs)是由氢键供体与受体按一定摩尔比组成的低熔点二元或多元组分体系,因其优异的溶解性能、灵活的结构可设计性及良好的生物相容性,在药物递送领域展现出广阔应用前景。阐述DESs的构建原理及其理化性质,系统分析其在药剂学中的主要应用,包括作为增溶剂、吸收促进剂和稳定剂等。综述基于活性药物成分(active pharmaceutical ingredient,API)的深共熔物(API-DES)的研究现状,探讨其在新型载体设计及功能化中的应用,如胶束、反胶束、纳米乳、凝胶、自组装纳米粒及免疫佐剂等,同时展望DESs的临床转化前景及其面临挑战与发展方向,旨在为其在药物制剂领域的深入研究和应用提供参考。

     

    Abstract: Deep eutectic solvents(DESs), low-melting-point binary or multicomponent systems formed by combining hydrogen bond donors and acceptors at specific molar ratios, have garnered increasing attention as promising platforms for drug delivery owing to their superior solubilizing ability, structural tunability, and biocompatibility. This review presents a comprehensive overview of the design principles and physicochemical characteristics of DESs, with a particular focus on their functional roles as solubilizers, permeation enhancers, and stabilizing agents in pharmaceutical formulations. Special emphasis is placed on active pharmaceutical ingredient(API)-based DESs, which incorporate active pharmaceutical ingredients into DESs, with a critical examination of the potential of DES in the engineering of advanced delivery carriers, such as micelles, reversed micelles, nanoemulsions, gels, self-assembled nanoparticles, and immunoadjuvants, and a prospect of the translational prospects, current limitations, and future research directions, aiming to provide some reference for their in-depth research and application in the field of drug preparations.

     

/

返回文章
返回